Trademark: 86972629
Status Date
Monday, October 15, 2018
Filing Date
Tuesday, April 12, 2016
Published for Opposition
Tuesday, January 17, 2017
Abandoned Date
Monday, October 15, 2018
5 pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease
Oct 15, 2018
Abandonment Notice Mailed - No Use Statement Filed
Oct 15, 2018
Abandonment - No Use Statement Filed
Feb 9, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2018
Extension 2 Granted
Feb 7, 2018
Extension 2 Filed
Feb 7, 2018
Teas Extension Received
Jun 15, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 13, 2017
Extension 1 Granted
Jun 13, 2017
Extension 1 Filed
Jun 13, 2017
Teas Extension Received
Mar 14, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 17, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 17, 2017
Published For Opposition
Dec 28, 2016
Notification Of Notice Of Publication E-Mailed
Dec 13, 2016
Law Office Publication Review Completed
Dec 12, 2016
Assigned To Lie
Nov 23, 2016
Approved For Pub - Principal Register
Nov 7, 2016
Teas/Email Correspondence Entered
Nov 7, 2016
Correspondence Received In Law Office
Nov 2, 2016
Assigned To Lie
Oct 24, 2016
Teas Response To Office Action Received
Jul 28, 2016
Notification Of Non-Final Action E-Mailed
Jul 28, 2016
Non-Final Action E-Mailed
Jul 28, 2016
Non-Final Action Written
Jul 27, 2016
Assigned To Examiner
Apr 15, 2016
New Application Office Supplied Data Entered In Tram
Apr 15, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
